Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Launch Supplement

University of Toronto

$12,500.00

Engineering inflammation-responsive polymer materials for gastrointestinal biosensing

FY 2024-25

Summary
The proposed program aims to engineer stimuli-responsive materials to develop an oral pill for biosensing in the gastrointestinal tract using inflammation-responsive polymers. Technologies that enable regular monitoring of inflammation in chronic inflammatory diseases like inflammatory bowel disease (IBD) are critical to patient care, offering earlier disease diagnosis and higher resolution disease monitoring for preventative care. However, techniques used for IBD diagnosis like endoscopy and imaging (MRI, CT) require specialized personnel and trips to a healthcare provider and are not suitable for frequent disease monitoring. There are fecal biomarkers (ex. fecal calprotectin) that can be detected in lab tests or at-home lateral flow assays, but patient compliance is poor for these tests because they require collection and manipulation of stool samples. As a result, monitoring fecal calprotectin using stool sampling has not been successfully implemented as a tool for regular inflammation monitoring. A test to monitor the onset of inflammation associated with IBD flare-ups that is patient administered, non-invasive, and does not require stool manipulation would enable treatment before the manifestation of symptoms, revolutionizing IBD treatment strategies. In this work, we will synthesize inflammation-responsive polymer materials that will be used to engineer simple, orally administered biosensors for inflammation monitoring in the gastrointestinal tract. Our goal is that these biosensor pills will have a simple readout that does not require stool manipulation (ex. colourmetric readouts). Stimuli-responsive polymers that have previously been developed for drug delivery applications, have potential to be adapted for local inflammation biosensing. For example, reactive oxygen species (ROS)-responsive polymers that degrade in inflamed environments can be used to develop simple polymer-based biosensors. We will use principles from drug delivery, materials science, and engineering to design platform technologies that have potential application in a number of gastrointestinal diseases for inflammation monitoring. Our approach aims to develop polymer materials-based biosensor devices that release dye in response to inflammatory biomarkers (ex. ROS). The dye released is excreted in patient stool and colours both stool and toilet water noticeably for an easy signal readout by patients. Moreover, these technologies could also be adapted for monitoring ROS in the environment, for example in soil, as a metric of environmental stress. The proposed aims have the potential to advance the biomaterials field, by developing new stimuli-responsive materials and demonstrating their application for enabling biosensor technologies. In the future, these new materials will enable new tools for disease management that will improve patient outcomes in digestive diseases like IBD and contribute to establishing Canada as a leader in disease detection and monitoring.
Program
Discovery Launch Supplement
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
DGECR-2024-00484
Name nom
Maikawa, Caitlin
Department département
Institute of Biomedical Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
12500
Program id
DGECR
Program name en
Discovery Launch Supplement
Program name fr
Supplément Tremplin vers la découverte
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Engineering inflammation-responsive polymer materials for gastrointestinal biosensing
Keywords
stimuli-responsive polymers; biomaterials; biosensing
Application summary
The proposed program aims to engineer stimuli-responsive materials to develop an oral pill for biosensing in the gastrointestinal tract using inflammation-responsive polymers. Technologies that enable regular monitoring of inflammation in chronic inflammatory diseases like inflammatory bowel disease (IBD) are critical to patient care, offering earlier disease diagnosis and higher resolution disease monitoring for preventative care. However, techniques used for IBD diagnosis like endoscopy and imaging (MRI, CT) require specialized personnel and trips to a healthcare provider and are not suitable for frequent disease monitoring. There are fecal biomarkers (ex. fecal calprotectin) that can be detected in lab tests or at-home lateral flow assays, but patient compliance is poor for these tests because they require collection and manipulation of stool samples. As a result, monitoring fecal calprotectin using stool sampling has not been successfully implemented as a tool for regular inflammation monitoring. A test to monitor the onset of inflammation associated with IBD flare-ups that is patient administered, non-invasive, and does not require stool manipulation would enable treatment before the manifestation of symptoms, revolutionizing IBD treatment strategies. In this work, we will synthesize inflammation-responsive polymer materials that will be used to engineer simple, orally administered biosensors for inflammation monitoring in the gastrointestinal tract. Our goal is that these biosensor pills will have a simple readout that does not require stool manipulation (ex. colourmetric readouts). Stimuli-responsive polymers that have previously been developed for drug delivery applications, have potential to be adapted for local inflammation biosensing. For example, reactive oxygen species (ROS)-responsive polymers that degrade in inflamed environments can be used to develop simple polymer-based biosensors. We will use principles from drug delivery, materials science, and engineering to design platform technologies that have potential application in a number of gastrointestinal diseases for inflammation monitoring. Our approach aims to develop polymer materials-based biosensor devices that release dye in response to inflammatory biomarkers (ex. ROS). The dye released is excreted in patient stool and colours both stool and toilet water noticeably for an easy signal readout by patients. Moreover, these technologies could also be adapted for monitoring ROS in the environment, for example in soil, as a metric of environmental stress. The proposed aims have the potential to advance the biomaterials field, by developing new stimuli-responsive materials and demonstrating their application for enabling biosensor technologies. In the future, these new materials will enable new tools for disease management that will improve patient outcomes in digestive diseases like IBD and contribute to establishing Canada as a leader in disease detection and monitoring.